| Date | Event | Description |
|---|---|---|
| 25 May 2021 | Amended | Merged with Vascular endothelial growth factor (VEGF) targeting therapy for persistent, recurrent, or metastatic cervical cancer. See www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013348.pub2/full. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.